FDA OKs Lusutrombopag for Thrombocytopenia in Liver Disease

Share this post

The thrombopoietin receptor agonist is for adults with chronic liver disease who are scheduled to undergo a medical or dental procedure.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply